Medpace Holdings Inc vs Suncor Energy Inc. — how do they compare? Medpace Holdings Inc trades at $602 (market cap $16.82B), while Suncor Energy Inc. trades at $70.57 (market cap $82.76B). The key difference: Suncor Energy Inc. is far larger — about 4.9× Medpace Holdings Inc's market cap, and Suncor Energy Inc. pays a 2.39% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Suncor Energy Inc. for 57 Days on average.
| MEDP | SU | |
|---|---|---|
Market Cap | $16.82B | $82.76B |
Volume | 223,093 | 3,832,959 |
Sector | Health | Energy |
52-Week High | $630.19 | $71.87 |
52-Week Low | $393.42 | $38.17 |
Typical Hold Time | 14 Days | 57 Days |
Enterprise Value | $16.44B | $89.29B |
Dividend Yield | — | 2.39% |
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $604.25, up 0.22% with neutral technical signals and strong fundamental performance. The stock shows robust profitability with 17.67% net income margin and consistent earnings beats in recent quarters. Recent news highlights institutional activity including CEO stock sales and upcoming Q3 2026 earnings report on October 21, 2026. Technical indicators show mixed signals with RSI neutral and ADX bullish, while support sits at $589 and resistance at $629.
MEDP presents a mixed outlook with strong fundamentals offset by high valuations and insider selling. The 21% buy rating from analysts suggests cautious optimism, with $620.44 price target offering 2.7% upside. Key risks include elevated P/E ratio of 35.5 and recent CEO stock sales totaling over $44 million in September 2026. Positive cash flow projection for 2026 supports growth potential despite current net outflow.
Suncor Energy (SU) trades at $68.14, down 0.12% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a P/E of 12.98, ROE of 19.25%, and consistent earnings beats in recent quarters. Recent news highlights strategic asset sales and leadership transitions, while analyst consensus remains strongly positive with 74% buy ratings. Cash flow trends show operational strength with $12.78B from operations in 2025.
SU presents a compelling value opportunity with attractive valuation metrics and robust shareholder returns through dividends and buybacks. Key risks include commodity price volatility and operational challenges from weather disruptions. The company's integrated model and international revenue diversification provide stability, though investors should monitor execution under new leadership and global energy market conditions.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →